Isosorbide clinical trials
How each study uses Isosorbide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Isosorbide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Jan 1974 · ISMOTIC · NDA 017063 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Brand
- Isobide
- 1
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Alvogen Korea (1) · Vanderbilt University (1) · Lunan Better Pharmaceutical Co., LTD. (1) · AbClon (1)
Often tested with
Tested in the same studies.
Omega-N-Methylarginine (1) · Bradykinin (1) · Sildenafil (1) · Anti-CD19 CAR T Cells AT101 (1) · Gossypol-acetic acid (1) · Gossypol acetic acid (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test Isosorbide, phase 3 first.
- Jun 2027Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's DiseasePhase 2/3 · Lunan Better Pharmaceutical Co., LTD.
Studies
Open first, then newest update. How each study uses Isosorbide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's DiseaseNot yet recruitingPhase 2/3Lunan Better Pharmaceutical Co., LTD.NCT06765993Written as Isosorbide oral solution
- Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaRecruitingPhase 1/2AbClonNCT05338931Written as AT101(Anti-CD19 Chimeric Antigen Receptor T cell)
- Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace TabletsCompletedPhase 4Alvogen KoreaNCT02718846Written as Isobide
- Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3CompletedNot applicableVanderbilt UniversityNCT00685945Written as Isosorbide + L-NMMA + bradykinin
Codes
What other systems call Isosorbide · ClinicalTrials.gg INT007697
- MeSH (NLM) D007547IsosorbideConfirmed NLM, Wikidata
- UNII (FDA) WXR179L51SISOSORBIDEConfirmed FDA, NLM, Wikidata
- RxNorm 6057Confirmed FDA, Wikidata
- Wikidata Q1243800isosorbideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C60773IsosorbideOne source FDA
- DrugBank DB09401One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007547 | Isosorbide | Confirmed NLM, Wikidata |
| UNII (FDA) | WXR179L51S | ISOSORBIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6057 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1243800 | isosorbide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C60773 | Isosorbide | One source FDA |
| DrugBank | DB09401 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.